Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of algorithms for prandial insulin dose calculation considering fat and protein content in type 1 diabetes with insulin pump therapy
2017-001807-62Phase 4Active
- Sponsor
- Forschungsinstitut der Diabetes-Akademie Bad Mergentheim
- Start
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of insulin aspart, insulin lispro, insulin glulisine and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Forschungsinstitut der Diabetes-Akademie Bad Mergentheim. Started Jun 2017; status: active.
02
Drugs
insulin aspartinsulin lisproinsulin glulisinehuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2017-001807-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001807-62.